Amanda M. Loya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amanda M. Loya has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
José O. Rivera
2 shared publications- Margie E. Padilla
The University of Texas at El Paso School of Pharmacy, 500 W. University, El Paso, TX 79968, USA
2 shared publications Abigail Strate
El Paso, USA
1 shared publication- Aida Oganesyan
West Coast University. Los Angeles, CA (United States).
1 shared publication Armando González-Stuart
The University of Texas at El Paso College of Health Sciences
1 shared publication- Celeste M. Vinluan
West Coast University. Los Angeles, CA (United States).
1 shared publication
Latest Publications
- 7 October 2024
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (1) , 102204
Don't worry, be APPE: Developing and refining a skills-based assessment of student preparedness for advanced pharmacy practice experiences
- 7 October 2024
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 17 (1) , 102204
Don't worry, be APPE: Developing and refining a skills-based assessment of student preparedness for advanced pharmacy practice experiences
- 26 June 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (9) , 100744
Importance of Understanding Minority-Serving Institutional Designations and Associated Abbreviations in Contemporary US Higher Education
- 26 June 2024
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 88 (9) , 100744
Importance of Understanding Minority-Serving Institutional Designations and Associated Abbreviations in Contemporary US Higher Education
- Open Access
- 28 April 2021
- Published by Springer Nature in Medical Science Educator
- Vol. 31 (3) , 1073-1081
Improving Medical Students Learning Through an Interprofessional Pharmacotherapy Selective
Purpose Current trends in medical school education indicate an existing need for increasing medical student exposure to pharmacotherapy education. The objectives of this study are to describe the development of an interprofessional, application-based Pharmacotherapeutics in Primary Care selective for 3rd year medical students and to assess its influence on knowledge, attitudes, and skills related to pharmacotherapy of high-risk medications and patient populations. Methods The selective was implemented across fourteen cohorts of medical students that were evaluated over a 5-year academic period (n = 68). Our curriculum was unique in that it merged basic pharmacology and pharmacotherapy concepts with application-based medication management of high-risk patients in addition to the incorporation of an interprofessional home visit experience. Results Pre- and post-assessment analyses found statistically significant improvements in students’ pharmacotherapeutic knowledge and skills. There was a significant increase in the knowledge post-test mean score (71.8; SD = 11.2) compared to the pre-test mean score (57.3; SD = 11.9; P < .001). A similar trend was observed for the skills mean score in which the post-test average (63; SD = 16.9) was significantly higher than the pretest average (23.3; SD = 14.4; P < 0.001). Students’ attitudes also improved when rating their confidence in completing specific tasks such as recommending dosing regimens and utilizing drug information resources. Conclusion This intervention provided 3rd-year medical students with opportunities to improve their knowledge, attitudes, and skills related to the pharmacotherapeutic management of high-risk medications and patient populations while exploring meaningful interprofessional interactions with faculty and learners from other disciplines.
- 28 April 2021
- Published by Springer Nature in Medical Science Educator
- Vol. 31 (3) , 1073-1081
Open AccessImproving Medical Students Learning Through an Interprofessional Pharmacotherapy Selective
Purpose Current trends in medical school education indicate an existing need for increasing medical student exposure to pharmacotherapy education. The objectives of this study are to describe the development of an interprofessional, application-based Pharmacotherapeutics in Primary Care selective for 3rd year medical students and to assess its influence on knowledge, attitudes, and skills related to pharmacotherapy of high-risk medications and patient populations. Methods The selective was implemented across fourteen cohorts of medical students that were evaluated over a 5-year academic period (n = 68). Our curriculum was unique in that it merged basic pharmacology and pharmacotherapy concepts with application-based medication management of high-risk patients in addition to the incorporation of an interprofessional home visit experience. Results Pre- and post-assessment analyses found statistically significant improvements in students’ pharmacotherapeutic knowledge and skills. There was a significant increase in the knowledge post-test mean score (71.8; SD = 11.2) compared to the pre-test mean score (57.3; SD = 11.9; P < .001). A similar trend was observed for the skills mean score in which the post-test average (63; SD = 16.9) was significantly higher than the pretest average (23.3; SD = 14.4; P < 0.001). Students’ attitudes also improved when rating their confidence in completing specific tasks such as recommending dosing regimens and utilizing drug information resources. Conclusion This intervention provided 3rd-year medical students with opportunities to improve their knowledge, attitudes, and skills related to the pharmacotherapeutic management of high-risk medications and patient populations while exploring meaningful interprofessional interactions with faculty and learners from other disciplines.
- 1 December 2019
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 11 (12) , 1205-1212
Identifying opportunities for PharmD curricular reform by surveying oncology pharmacists about career preparedness and exposure
- 1 December 2019
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 11 (12) , 1205-1212
Identifying opportunities for PharmD curricular reform by surveying oncology pharmacists about career preparedness and exposure
- Open Access
- 31 December 2018
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 16 (4) , 1283
A retrospective analysis of prescription medications as it correlates to falls for older adults
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 31 December 2018
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 16 (4) , 1283
Open AccessA retrospective analysis of prescription medications as it correlates to falls for older adults
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 1 November 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (6) , e194-e198
Medication use practices and perceptions among patients in a U.S.–Mexico border community
- 1 November 2012
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 52 (6) , e194-e198
Medication use practices and perceptions among patients in a U.S.–Mexico border community
- 1 May 2009
- Published by Springer Nature in Drugs & Aging
- Vol. 26 (5) , 423-436
Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico Border
The use of multiple medications, herbs or nutritional supplements can lead to adverse consequences, particularly in the elderly. A significant consequence resulting from polypharmacy, polyherbacy and nutritional supplement use is the potential for interactions to occur among the various products. The primary objective of this study was to estimate the prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the US-Mexico border. This was a descriptive study that involved the administration of a bilingual (English/Spanish) questionnaire to a convenience sample of adults aged ≥60 years recruited from senior centres located within the most populated US-Mexico border region from June 2005 to March 2006. Participant demographics were collected in addition to information about current use of prescription medications, over-the-counter (OTC) medications, herbal products and nutritional supplements (i.e. nutraceuticals and vitamins or minerals). The outcomes measured were the number of prescription medications, OTC medications, herbal products, vitamins/minerals and nutraceuticals per participant. Furthermore, the number of potential interactions and major interactions between drugs, herbal products and nutritional supplements were identified for each participant. Additionally, product use patterns between men and women and among locations within the border region were compared. One-hundred-and-thirty participants (mean age 71.4 years) were recruited to complete the questionnaire. The prevalence of polypharmacy among all participants was 72.3% (n = 94), with 38.5% (n = 50) taking five or more concomitant medications (major polypharmacy). Twenty-one participants (16.2%) in the study sample reported taking two or more herbal products (polyherbacy). Thirty-four participants (26.2%) reported taking two or more vitamin/mineral supplements and nine (6.9%) reported using two or more nutraceuticals. Participants living on the US side of the border had higher rates of major polypharmacy, polyherbacy and use of nutritional supplements than those living on the Mexican side of the border. Overall, there were no significant differences in medication, herbal product and nutritional supplement use patterns between men and women. Evaluation of potential interactions revealed that 46.2% (n = 60) of participants were at risk of having at least one potential drug-drug interaction. Regarding drug and herbal product-supplement interactions, 31.5% (n = 41) of participants were at risk of having at least one possible interaction. The prevalence of polypharmacy among older adults living on the US side of the border was similar to national trends (estimates suggest that one-quarter to one-half of US adults aged ≥65 years take five or more medications). However, polypharmacy was less common in older adults living on the Mexican side of the border. Additionally, herb use was higher in older adults living on the US-Mexico border than has been reported in national surveys of US adults, which indicate that less than one-quarter of adults have used a herbal product within the previous 12 months. Furthermore, this study demonstrated that older adults living on the US side of the border consumed more herbs and nutritional supplements than their Mexican counterparts. In addition to describing product use patterns on the border, these findings suggest that almost half of the older adult participants were at risk for a potential drug-drug interaction, with approximately one-third having a potential interaction between their medications, herbs or nutritional supplements.
- 1 May 2009
- Published by Springer Nature in Drugs & Aging
- Vol. 26 (5) , 423-436
Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico Border
The use of multiple medications, herbs or nutritional supplements can lead to adverse consequences, particularly in the elderly. A significant consequence resulting from polypharmacy, polyherbacy and nutritional supplement use is the potential for interactions to occur among the various products. The primary objective of this study was to estimate the prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the US-Mexico border. This was a descriptive study that involved the administration of a bilingual (English/Spanish) questionnaire to a convenience sample of adults aged ≥60 years recruited from senior centres located within the most populated US-Mexico border region from June 2005 to March 2006. Participant demographics were collected in addition to information about current use of prescription medications, over-the-counter (OTC) medications, herbal products and nutritional supplements (i.e. nutraceuticals and vitamins or minerals). The outcomes measured were the number of prescription medications, OTC medications, herbal products, vitamins/minerals and nutraceuticals per participant. Furthermore, the number of potential interactions and major interactions between drugs, herbal products and nutritional supplements were identified for each participant. Additionally, product use patterns between men and women and among locations within the border region were compared. One-hundred-and-thirty participants (mean age 71.4 years) were recruited to complete the questionnaire. The prevalence of polypharmacy among all participants was 72.3% (n = 94), with 38.5% (n = 50) taking five or more concomitant medications (major polypharmacy). Twenty-one participants (16.2%) in the study sample reported taking two or more herbal products (polyherbacy). Thirty-four participants (26.2%) reported taking two or more vitamin/mineral supplements and nine (6.9%) reported using two or more nutraceuticals. Participants living on the US side of the border had higher rates of major polypharmacy, polyherbacy and use of nutritional supplements than those living on the Mexican side of the border. Overall, there were no significant differences in medication, herbal product and nutritional supplement use patterns between men and women. Evaluation of potential interactions revealed that 46.2% (n = 60) of participants were at risk of having at least one potential drug-drug interaction. Regarding drug and herbal product-supplement interactions, 31.5% (n = 41) of participants were at risk of having at least one possible interaction. The prevalence of polypharmacy among older adults living on the US side of the border was similar to national trends (estimates suggest that one-quarter to one-half of US adults aged ≥65 years take five or more medications). However, polypharmacy was less common in older adults living on the Mexican side of the border. Additionally, herb use was higher in older adults living on the US-Mexico border than has been reported in national surveys of US adults, which indicate that less than one-quarter of adults have used a herbal product within the previous 12 months. Furthermore, this study demonstrated that older adults living on the US side of the border consumed more herbs and nutritional supplements than their Mexican counterparts. In addition to describing product use patterns on the border, these findings suggest that almost half of the older adult participants were at risk for a potential drug-drug interaction, with approximately one-third having a potential interaction between their medications, herbs or nutritional supplements.